Amicus’ Galafold wins US approval

13th August 2018 Uncategorised 0

Amicus Therapeutics’ Galafold has been approved in the US as the first oral medication for the treatment of adults with Fabry disease.

More: Amicus’ Galafold wins US approval
Source: News